# Fortune Brands Innovations, Inc.: Form 10-Q for the period ended Sep 30, 2014

- Company: [Fortune Brands Innovations, Inc.](/companies/fbin.md) (CIK 1519751)
- Form: 10-Q
- Filed: 2014-10-31
- Accepted by EDGAR: Oct 31, 2014, 16:06 ET
- Period: 2014-09-30
- Accession: 0001193125-14-392024
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1519751/000119312514392024/d799406d10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1519751/000119312514392024/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2014-07-01 to 2014-09-30 | $1.10bn | us-gaap:SalesRevenueNet |
| Revenue | 9 months, 2014-01-01 to 2014-09-30 | $3.07bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2014-07-01 to 2014-09-30 | $719.4m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months, 2014-01-01 to 2014-09-30 | $2.02bn | us-gaap:CostOfGoodsSold |
| Selling, general and administrative | 3 months, 2014-07-01 to 2014-09-30 | $238.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2014-01-01 to 2014-09-30 | $699.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2014-07-01 to 2014-09-30 | $136.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2014-01-01 to 2014-09-30 | $337.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2014-07-01 to 2014-09-30 | $3.2m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2014-01-01 to 2014-09-30 | $7.2m | us-gaap:InterestExpense |
| Income tax | 3 months, 2014-07-01 to 2014-09-30 | $44.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2014-01-01 to 2014-09-30 | $105.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2014-07-01 to 2014-09-30 | −$21.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2014-01-01 to 2014-09-30 | $113.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2014-07-01 to 2014-09-30 | −$0.13 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2014-01-01 to 2014-09-30 | $0.67 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2014-07-01 to 2014-09-30 | −$0.13 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2014-01-01 to 2014-09-30 | $0.69 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2014-07-01 to 2014-09-30 | 163,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2014-01-01 to 2014-09-30 | 167,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2014-01-01 to 2014-09-30 | $110.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2014-01-01 to 2014-09-30 | $82.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2014-01-01 to 2014-09-30 | $58.5m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months, 2014-01-01 to 2014-09-30 | $411.4m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2014-09-30 | $175.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-09-30 | $1.36bn | us-gaap:AssetsCurrent |
| Total assets | at 2014-09-30 | $4.08bn | us-gaap:Assets |
| Current liabilities | at 2014-09-30 | $710.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2014-09-30 | $1.74bn | us-gaap:Liabilities |
| Long-term debt | at 2014-09-30 | $653.8m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2014-09-30 | $26.2m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2014-09-30 | $2.34bn | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1519751/000119312514392024/d799406d10q.htm

Filed Oct 31, 2014.
Source: SEC EDGAR, the filing index for accession 0001193125-14-392024. Last ingested by Listed: Nov 10, 2026, 02:09 ET. No prices; not investment advice.
